Critical Care Medicine

Skip Navigation LinksHome > May 2013 - Volume 41 - Issue 5 > The Use of Neuromuscular Blocking Agents in the ICU: Where...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e31828ce07c
Concise Definitive Review

The Use of Neuromuscular Blocking Agents in the ICU: Where Are We Now?

Greenberg, Steven B. MD1,2; Vender, Jeffery MD, MBA, FCCP, FCCM1,2

Collapse Box


Intensivists use neuromuscular blocking agents for a variety of clinical conditions, including for emergency intubation, acute respiratory distress syndrome, status asthmaticus, elevated intracranial pressure, elevated intra-abdominal pressure, and therapeutic hypothermia after ventricular fibrillation–associated cardiac arrest. The continued creation and use of evidence-based guidelines and protocols could ensure that neuromuscular blocking agents are used and monitored appropriately. A collaborative multidisciplinary approach coupled with constant review of the pharmacology, dosing, drug interactions, and monitoring techniques may reduce the adverse events associated with the use of neuromuscular blocking agents.

© 2013 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.